Travere Therapeutics, Inc. ($TVTX)
Filing Information
| Accession Number | 0001943192-26-000003 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 16, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
22,327
Total Value
$348,974.00
P&L
+inf% (+$553,560.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHIEF FINANCIAL OFFICER | Common Stock | โ | Apr 13, 2026 | Grant/Award | 14,000 | $0.00 | $0.00 | 125,226 | Direct | โ | View Details | |
CHIEF FINANCIAL OFFICER | Common Stock | โ | Apr 13, 2026 | Sale | 65 | $28.85 | $1,875.25 | 125,161 | Direct | โ | View Details | |
CHIEF FINANCIAL OFFICER | Common Stock | โ | Apr 14, 2026 | Sale | 9 | $41.07 | $369.63 | 125,152 | Direct | โ | View Details | |
CHIEF FINANCIAL OFFICER | Common Stock | โ | Apr 14, 2026 | Sale | 7,239 | $41.93 | $303,522.58 | 117,913 | Direct | โ | View Details | |
CHIEF FINANCIAL OFFICER | Common Stock | โ | Apr 15, 2026 | Sale | 1,014 | $42.61 | $43,206.54 | 116,899 | Direct | โ | View Details |